XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance at Jan. 31, 2021 $ 53,323 $ 204,988 $ (808) $ 257,503
Balance (in Shares) at Jan. 31, 2021 11,888,000      
Net income (loss)   15,691   15,691
Unrealized gain loss on defined benefit plan, net of tax     229 229
Cash dividends paid and accrued   (6,437)   (6,437)
Restricted stock grants, net of forfeitures $ (125)     (125)
Restricted stock grants, net of forfeitures (in Shares) 34,000      
Restricted stock compensation cost $ 813     813
Performance-based restricted stock units costs 419     419
PSU awards (740)     (740)
Balance at Oct. 31, 2021 $ 53,690 214,242 (579) 267,353
Balance (in Shares) at Oct. 31, 2021 11,922,000      
Balance at Aug. 01, 2021 $ 53,473 217,613 (655) 270,431
Balance (in Shares) at Aug. 01, 2021 11,924,000      
Net income (loss)   (1,219)   (1,219)
Unrealized gain loss on defined benefit plan, net of tax     76 76
Cash dividends paid and accrued   (2,152)   (2,152)
Restricted stock grants, net of forfeitures $ (125)     (125)
Restricted stock grants, net of forfeitures (in Shares) (2,000)      
Restricted stock compensation cost $ 216     216
Performance-based restricted stock units costs 126     126
Balance at Oct. 31, 2021 $ 53,690 214,242 (579) 267,353
Balance (in Shares) at Oct. 31, 2021 11,922,000      
Balance at Jan. 30, 2022 $ 53,295 207,884 (51) $ 261,128
Balance (in Shares) at Jan. 30, 2022 11,922,000     11,922,000
Net income (loss)   13,566   $ 13,566
Unrealized gain loss on defined benefit plan, net of tax     47 47
Cash dividends paid and accrued   (7,117)   (7,117)
Purchase and retirement of common stock $ (2,751) (6,608)   (9,359)
Purchase and retirement of common stock (in Shares) (598,000)      
Restricted stock grants, net of forfeitures $ (102)     (102)
Restricted stock grants, net of forfeitures (in Shares) 97,000      
Restricted stock compensation cost $ 963     963
Performance-based restricted stock units costs 463     463
Balance at Oct. 30, 2022 $ 51,868 207,725 (4) $ 259,589
Balance (in Shares) at Oct. 30, 2022 11,421,000     11,421,000
Balance at Jul. 31, 2022 $ 53,853 210,994 (19) $ 264,828
Balance (in Shares) at Jul. 31, 2022 11,959,000      
Net income (loss)   4,841   4,841
Unrealized gain loss on defined benefit plan, net of tax     15 15
Cash dividends paid and accrued   (2,323)   (2,323)
Purchase and retirement of common stock $ (2,436) (5,787)   (8,223)
Purchase and retirement of common stock (in Shares) (530,000)      
Restricted stock grants, net of forfeitures (in Shares) (8,000)      
Restricted stock compensation cost $ 297     297
Performance-based restricted stock units costs 154     154
Balance at Oct. 30, 2022 $ 51,868 $ 207,725 $ (4) $ 259,589
Balance (in Shares) at Oct. 30, 2022 11,421,000     11,421,000